Biomedical Engineering Reference
In-Depth Information
8. Barton ME, Eberle EL, Shannon HE (2005) The antihyperalgesic effects of the T-type
calcium channel blockers ethosuximide, trimethadione, and mibefradil. Eur J Pharmacol
521:79-85
9. Coulter DA, Huguenard JR, Prince DA (1989) Calcium currents in rat thalamocortical relay
neurons: kinetic properties of the transient, low-threshold current. Ann Neurol 25:582-593
10. Coulter DA, Huguenard JR, Prince DA (1990) Differential effects of petit mal
anticonvulsants and convulsants on thalamic neurones: GABA current blockade. Br
J Pharmacol 100:800-806
11. Nelson MT, Todorovic SM (2006) The role of T-type calcium channels in epilepsy and pain.
Curr Pharm Des 12:2189-2197
12. Perez-Reyes E (2003) Molecular physiology of low-voltage-activated T-type calcium
channels. Physiol Rev 83:117-161
13. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International union of Pharma-
cology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium
channels. Pharmacol Rev 57:411-425
14. McRory JE, Santi CM, Hamming KSC, Mezeyova J, Sutton KG, Baillie DL, Stea A, Snutch
TP (2001) Molecular and functional characterization of a family of rat brain T-type calcium
channels. J Biol Chem 276:3999-4011
15. Shin H-S, Cheong E-J, Choi S, Lee J, Na HS (2008) T-type Ca
2
þ
channels as therapeutic
targets in the nervous system. Curr Opin Pharmacol 8:33-41
16. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A,
Snutch TP, Tanabe BL, Tsien RW, Catterall WA (2000) Nomenclature of voltage-gated
calcium channels. Neuron 25:533-535
17. Doering D, Zamponi G, Connolly TM, Barrow JC, Triggle DJ, Snutch TP (2006) Voltage-
gated ion channels as drug targets. Wiley-VCH, Weinhiem
18. McDonough SI, Bean BP (1998) Mibefradil inhibition of T-type calcium channels in
cerebellar Purkinje neurons. Mol Pharmacol 54:1080-1087
19. Mishra SK, Hermsmeyer K (1994) Selective inhibition of T-type Ca
2
þ
channels by Ro
40-5967. Circ Res 75:144-148
20. SoRelle R (1998) Withdrawal of Posicor from market. Circulation 98:831-832
21. Flatters SJL (2005) T-type calcium channels: a potential target for the treatment of chronic
pain. Drugs Future 30:573-580
22. Hoth M (1995) Calcium and barium permeation through calcium release-activated calcium
(CRAC) channels. Pflugers Arch 430(3):315-322
23. Hoth M, Penner R (1992) Depletion of intracellular calcium stores activates a calcium
current in mast cells. Nature 355:353-356
24. Lewis RS, Cahalan MD (1995) Potassium and calcium channels in lymphocytes. Annu Rev
Immunol 13:623-653
25. Clementi E, Meldolesi J (1996) Pharmacological and functional properties of voltagemi
independent Ca
2
þ
channels. Cell Calcium 19:269-279
26. Geiszt M, Kapus A, Nemet K, Farkas L, Ligeti E (1997) Regulation of capacitative Ca
2
þ
influx in human neutrophil granulocytes. Alterations in chronic granulomatous disease.
J Biol Chem 272:26471-26478
27. Clapham DE (1995) Calcium signaling. Cell 80:259-268
28. Gray LS, Perez-Reyes E, Gamorra JC, Haverstick DM, Shattock M, McLatchie L, Harper J,
Brooks G, Heady T, Macdonald TL (2004) The role of voltage gated T-type Ca
2
þ
channel
isoforms in mediating “capacitative” Ca
2
þ
entry in cancer cells. Cell Calcium 36(6):489-497
29. Portegies MC, Schmitt R, Kraaij CJ, Braat SHJG, Gassner A, Hagemeijer F, Ponzenel H,
Prager G, Viersma JW, VanderWall EE, Kleinbloesem CH, Lie KI (1991) Lack of negative
inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina
pectoris. J Cardiovasc Pharmacol 18:746-751
